WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Sara L. Patak
Partner
Patents and Innovations
Boulder
spennebaker@wsgr.com

D303-256-5906

Download vCard
Open PDF

Sara L. Patak is a partner in the Boulder office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on patent prosecution and intellectual property counseling, serving clients in a wide range of technology fields, including the pharmaceutical and biotechnology industries.

During law school, Sara was an extern for licensing officers in the invention transfer group at UC Irvine Applied Innovation, where she assisted in the drafting and negotiating of university patent licenses and inter-institutional agreements, as well as conducted patentability and marketability assessments for UC Irvine intellectual property. Under the direction of an attorney supervisor, Sara also counseled several pro bono clients in the UC Irvine Intellectual Property, Arts, and Technology Law Clinic relating to copyright, patent, and trademark protection.

Sara gained extensive experience in cell biology, molecular biology, and biochemistry through her graduate and undergraduate research. During her graduate studies in the Tracy L. Johnson laboratory, she utilized cell culture models to study the post-transcriptional regulation of the transcription factor, Gcr1, in response to glucose availability. As an undergraduate, Sara's academic research in the Stephen Mayfield laboratory focused on agrobacterium-mediated transformation in algae for nutraceutical applications. She also gained additional research experience through an internship at Sapphire Energy, where she assisted in the initial characterization of a novel algal strain. In addition, during an internship at Scripps Institution of Oceanography, Sara studied the role of the invasive diatom, B.biddulphiana, and its impact on reef ecology, as well as investigated paternal genetic contributors in leopard shark populations.

Experience

Sara L. Patak is a partner in the Boulder office of Wilson Sonsini Goodrich & Rosati. Her practice focuses on patent prosecution and intellectual property counseling, serving clients in a wide range of technology fields, including the pharmaceutical and biotechnology industries.

During law school, Sara was an extern for licensing officers in the invention transfer group at UC Irvine Applied Innovation, where she assisted in the drafting and negotiating of university patent licenses and inter-institutional agreements, as well as conducted patentability and marketability assessments for UC Irvine intellectual property. Under the direction of an attorney supervisor, Sara also counseled several pro bono clients in the UC Irvine Intellectual Property, Arts, and Technology Law Clinic relating to copyright, patent, and trademark protection.

Sara gained extensive experience in cell biology, molecular biology, and biochemistry through her graduate and undergraduate research. During her graduate studies in the Tracy L. Johnson laboratory, she utilized cell culture models to study the post-transcriptional regulation of the transcription factor, Gcr1, in response to glucose availability. As an undergraduate, Sara's academic research in the Stephen Mayfield laboratory focused on agrobacterium-mediated transformation in algae for nutraceutical applications. She also gained additional research experience through an internship at Sapphire Energy, where she assisted in the initial characterization of a novel algal strain. In addition, during an internship at Scripps Institution of Oceanography, Sara studied the role of the invasive diatom, B.biddulphiana, and its impact on reef ecology, as well as investigated paternal genetic contributors in leopard shark populations.

Education
  • J.D., University of California, Irvine School of Law, 2017Magna Cum Laude
  • M.S., Molecular Biology, University of California, San Diego, 2013
  • B.S., Biochemistry and Cell Biology, University of California, San Diego, 2012
Admissions
  • State Bar of California
  • State Bar of Colorado
  • U.S. Patent and Trademark Office
Credentials
Education
  • J.D., University of California, Irvine School of Law, 2017Magna Cum Laude
  • M.S., Molecular Biology, University of California, San Diego, 2013
  • B.S., Biochemistry and Cell Biology, University of California, San Diego, 2012
Admissions
  • State Bar of California
  • State Bar of Colorado
  • U.S. Patent and Trademark Office

Select Publications

  • Co-author with M.A. Hossain, J.M. Claggett, S.R. Edwards, A. Shi, M.Y. Cheng, J. Hasty, and T.L. Johnson, "Posttranscriptional Regulation of Gcr1 Expression and Activity is Crucial for Metabolic Adjustment in Response to Glucose Availability," 62(3) Molecular Cell Journal 346-58, 2016
  • Co-author with J. Siegel, M. Arnold, A. Johnson, M. Li, M. Pessian, B. Tamsut, A. Zeng, and J. Zhang, "Rights holders need to keep faith in standard-essential patents," IAM Magazine, June 2016
  • Co-author with G.R. Galland, "A benthic diatom bloom in the Gulf of California, Mexico," 1(1) BioInvasions Records 65-9, 2012
Insights

Select Publications

  • Co-author with M.A. Hossain, J.M. Claggett, S.R. Edwards, A. Shi, M.Y. Cheng, J. Hasty, and T.L. Johnson, "Posttranscriptional Regulation of Gcr1 Expression and Activity is Crucial for Metabolic Adjustment in Response to Glucose Availability," 62(3) Molecular Cell Journal 346-58, 2016
  • Co-author with J. Siegel, M. Arnold, A. Johnson, M. Li, M. Pessian, B. Tamsut, A. Zeng, and J. Zhang, "Rights holders need to keep faith in standard-essential patents," IAM Magazine, June 2016
  • Co-author with G.R. Galland, "A benthic diatom bloom in the Gulf of California, Mexico," 1(1) BioInvasions Records 65-9, 2012

Biological Sciences and Biotechnology

  • Biochemical assays
  • Biochemistry
  • Cell biology
  • Cell therapy
  • Epigenetics
  • Genetics
  • Genomics
  • Molecular biology
  • PCR

Therapeutics and Drug Discovery

  • Drug delivery
  • Gene editing
  • Gene therapy
  • Pharmacogenomics

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics
  • Point-of-care testing (POCT)

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Next-generation sequencing
  • Sequencing
Technical Fluency

Biological Sciences and Biotechnology

  • Biochemical assays
  • Biochemistry
  • Cell biology
  • Cell therapy
  • Epigenetics
  • Genetics
  • Genomics
  • Molecular biology
  • PCR

Therapeutics and Drug Discovery

  • Drug delivery
  • Gene editing
  • Gene therapy
  • Pharmacogenomics

Diagnostics and Medical Devices

  • Bioinformatic
  • Diagnostics
  • Point-of-care testing (POCT)

Genomics and Data Analysis

  • Bioinformatics algorithms
  • Next-generation sequencing
  • Sequencing
Focus Areas
  • Animal Health
  • Diagnostics, Life Science Tools, and Deep Tech
  • Intellectual Property
  • Life Sciences
  • Patents and Innovations
  • Quantum Computing
Recent Insights
Client Highlights
Wilson Sonsini Advises Lead Investor on SHINE’s $240 Million Equity Funding
On February 27, 2026, SHINE Technologies, a nuclear fusion company, announced it has raised $240 million in equity funding led by NantWorks founder Dr. Patrick Soon-Shiong, with additional participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield Management, Oaktree Capital Management, and other existing investors. Wilson Sonsini Goodrich & Rosati advised lead investor OZ Shine LLC—a new investment company led by Dr. Soon-Shiong—on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Think Bioscience on Patent Matters Related to Oversubscribed $55 Million Series A
On January 20, 2026, Think Bioscience (Think Bio), a Boulder-based biotechnology company focused on unlocking elusive drug targets, has raised $55 million in an oversubscribed Series A. The round was led by Regeneron Ventures, Innovation Endeavors, and Janus Henderson Investors with participation from T.A. Springer, CE-Ventures, MBX Capital, and YK Bioventures. Returning investors include AV8 Ventures, CU Innovations, and Buff Gold Ventures. Wilson Sonsini Goodrich & Rosati advised Think Bio on patent matters related to the transaction.
Learn More
View All
Recent Events
Affiliated Programs
CBSA Thought Leadership Series: Intellectual Property
Wilson Sonsini is proud to sponsor the Colorado Bioscience Thought Leadership Series, a forum dedicated to exploring the critical strategic issues facing today’s life sciences companies.
Learn More
Affiliated Programs
26th Annual Berkeley-Stanford Advanced Patent Law Institute
Wilson Sonsini is pleased to support the 26th Annual Berkeley–Stanford Advanced Patent Law Institute, a premier program that brings together leading experts to discuss significant developments and emerging issues in patent law.
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.